SUVEN LIFE SCIENCES LTD. - Suven initiated Multiple Ascending Dose (MAD) studies in Phase 1 clinical Trial for their investigational compound SUVN-G3031
Download 
|
< Back |
| 13 Apr 2015 | |
| Suven Life Sciences Ltd has informed BSE regarding a Press Release dated April 13, 2015 titled "Suven initiated Multiple Ascending Dose (MAD) studies in Phase 1 clinical Trial for their investigational compound SUVN-G3031" | |
| View all announcements for SUVEN LIFE SCIENCES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback